TRUINJECT receives US patent approval

Truinject Corp. announced that the U.S. Patent Office has approved a patent for the company’s cosmetic and therapeutic injector training system, according to a press release.

The system will be tested among select doctors during the next several months, the release said.

“This is an incredibly detailed system using a true-to-life head model and a smart syringe,” Gabrielle Rios, TruInject founder and CEO, said in the press release. “Our goal is to create a comprehensive certified training system that accelerates the learning process for injectors of aesthetic fillers and toxins, increasing doctor skill and confidence in administering the procedures and helping assure patient safety.”

The system includes computer visuals that allow the trainee to peel back the model head layers to fully understand the injection procedure in relation to the needle, skin, muscle, nerves and bone layers it affects.

Whereas traditional training methods typically involve a great deal of time before doctors gain skill and confidence in their technique, the TruInject system is designed to help accelerate the learning period, according to the press release.